Increased Plasma Levels of Myosin Heavy Chain 11 Is Associated with Atherosclerosis

Many studies have revealed numerous potential biomarkers for atherosclerosis, but tissue-specific biomarkers are still needed. Recent lineage-tracing studies revealed that smooth muscle cells (SMCs) contribute substantially to plaque formation, and the loss of SMCs causes plaque vulnerability. We investigated the association of SMC-specific myosin heavy chain 11 (myosin-11) with atherosclerosis. Forty-five patients with atherosclerosis and 34 control subjects were recruited into our study. In the atherosclerosis patients, 35 patients had either coronary artery disease (CAD) or peripheral artery disease (PAD), and 10 had both CAD and PAD. Coronary arteries isolated from five patients were subjected to histological study. Circulating myosin-11 levels were higher in the CAD or PAD group than in controls. The area under the receiver operating characteristic curve of myosin-11 was 0.954. Circulating myosin-11 levels in the CAD and PAD group were higher than in the CAD or PAD group, while high-sensitivity C-reactive protein concentrations did not differ between these groups. Multinomial logistic regression analyses showed a significant association of myosin-11 levels with the presence of multiple atherosclerotic regions. Myosin-11 was expressed in the medial layer of human atherosclerotic lesions where apoptosis elevated. Circulating myosin-11 levels may be useful for detecting spatial expansion of atherosclerotic regions.

[1]  M. Jiménez-Palomares,et al.  Molecular signatures of athersoclerotic plaques: An up-dated panel of protein related markers. , 2020, Journal of proteomics.

[2]  Aditya M. Sharma,et al.  Low-cost preventive screening using carotid ultrasound in patients with diabetes. , 2020, Frontiers in bioscience.

[3]  A. Orekhov,et al.  MicroRNAs as Potential Biomarkers in Atherosclerosis , 2019, International journal of molecular sciences.

[4]  P. Libby,et al.  Atherosclerosis , 2019, Nature Reviews Disease Primers.

[5]  M. Bennett,et al.  Vascular smooth muscle cells in atherosclerosis , 2019, Nature Reviews Cardiology.

[6]  M. Bennett,et al.  Disease-relevant transcriptional signatures identified in individual smooth muscle cells from healthy mouse vessels , 2018, Nature Communications.

[7]  J. Golledge.  Abdominal aortic aneurysm: update on pathogenesis and medical treatments , 2018, Nature Reviews Cardiology.

[8]  Y. Ishikawa,et al.  Proteomic analysis of aortic smooth muscle cell secretions reveals an association of myosin heavy chain 11 with abdominal aortic aneurysm. , 2018, American journal of physiology. Heart and circulatory physiology.

[9]  P. M. da Silva,et al.  Standardization of laboratory and lipid profile evaluation: A call for action with a special focus in 2016 ESC/EAS dyslipidaemia guidelines - Full report. , 2018, Atherosclerosis. Supplements.

[10]  C. Fernández-Hernando,et al.  Integrin beta3 regulates clonality and fate of smooth muscle-derived atherosclerotic plaque cells , 2018, Nature Communications.

[11]  Jacob F Bentzon,et al.  Lineage tracking of origin and fate of smooth muscle cells in atherosclerosis. , 2018, Cardiovascular research.

[12]  K. Hamano,et al.  Current Status and Perspectives on Pharmacologic Therapy for Abdominal Aortic Aneurysm , 2017, Current drug targets.

[13]  E. Füchtbauer,et al.  Diverse cellular architecture of atherosclerotic plaque derives from clonal expansion of a few medial SMCs. , 2017, JCI insight.

[14]  G. Hansson,et al.  The immunology of atherosclerosis , 2017, Nature Reviews Nephrology.

[15]  Vagheesh M. Narasimhan,et al.  Extensive Proliferation of a Subset of Differentiated, yet Plastic, Medial Vascular Smooth Muscle Cells Contributes to Neointimal Formation in Mouse Injury and Atherosclerosis Models , 2016, Circulation research.

[16]  R. Stoika,et al.  Identification of a 48 kDa form of unconventional myosin 1c in blood serum of patients with autoimmune diseases , 2015, Biochemistry and biophysics reports.

[17]  M. Mayr,et al.  Novel methodologies for biomarker discovery in atherosclerosis. , 2015, European heart journal.

[18]  Laura S. Shankman,et al.  KLF4 Dependent Phenotypic Modulation of SMCs Plays a Key Role in Atherosclerotic Plaque Pathogenesis , 2015, Nature Medicine.

[19]  P. Shah.  Biomarkers of Plaque Instability , 2014, Current Cardiology Reports.

[20]  R. Feil,et al.  Transdifferentiation of Vascular Smooth Muscle Cells to Macrophage-Like Cells During Atherogenesis , 2014, Circulation research.

[21]  J. Gallacher,et al.  C-reactive protein, fibrinogen, and cardiovascular disease prediction. , 2012, The New England journal of medicine.

[22]  James A. Spudich,et al.  The myosin superfamily at a glance , 2012, Journal of Cell Science.

[23]  T. Littlewood,et al.  Bone Marrow–Derived Smooth Muscle–Like Cells Are Infrequent in Advanced Primary Atherosclerotic Plaques but Promote Atherosclerosis , 2011, Arteriosclerosis, thrombosis, and vascular biology.

[24]  Olli Saarela,et al.  Contribution of 30 Biomarkers to 10-Year Cardiovascular Risk Estimation in 2 Population Cohorts: The MONICA, Risk, Genetics, Archiving, and Monograph (MORGAM) Biomarker Project , 2010, Circulation.

[25]  V. Heinemann,et al.  Clinical Relevance of Circulating Nucleosomes in Cancer , 2008, Annals of the New York Academy of Sciences.

[26]  T. Littlewood,et al.  Chronic Apoptosis of Vascular Smooth Muscle Cells Accelerates Atherosclerosis and Promotes Calcification and Medial Degeneration , 2008, Circulation research.

[27]  J. Partanen,et al.  Developmental origin of smooth muscle cells in the descending aorta in mice , 2008, Development.

[28]  Katharina D'Herde,et al.  Apoptosis and necrosis: detection, discrimination and phagocytosis. , 2008, Methods.

[29]  E. Falk,et al.  Smooth Muscle Cells Healing Atherosclerotic Plaque Disruptions Are of Local, Not Blood, Origin in Apolipoprotein E Knockout Mice , 2007, Circulation.

[30]  W. Koenig,et al.  Biomarkers of Atherosclerotic Plaque Instability and Rupture , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[31]  P. Doevendans,et al.  Regulation and characteristics of vascular smooth muscle cell phenotypic diversity , 2007, Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation.

[32]  E. Falk,et al.  Smooth Muscle Cells in Atherosclerosis Originate From the Local Vessel Wall and Not Circulating Progenitor Cells in ApoE Knockout Mice , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[33]  T. Littlewood,et al.  Apoptosis of vascular smooth muscle cells induces features of plaque vulnerability in atherosclerosis , 2006, Nature Medicine.

[34]  Nedjma B. Zitouni,et al.  (+)Insert smooth muscle myosin heavy chain (SM-B) isoform expression in human tissues. , 2005, American journal of physiology. Cell physiology.

[35]  G. Owens,et al.  Molecular regulation of vascular smooth muscle cell differentiation in development and disease. , 2004, Physiological reviews.

[36]  E. K. Alpar,et al.  Levels of myosin heavy chain fragment in patients with tissue damage. , 2001, Archives of medical research.

[37]  A. Kalangos,et al.  Oxidized Low-Density Lipoprotein Is Associated With Apoptosis of Vascular Smooth Muscle Cells in Human Atherosclerotic Plaques , 2000, Circulation.

[38]  R. Virmani,et al.  The good smooth muscle cells in atherosclerosis , 2000, Current atherosclerosis reports.

[39]  H. C. Stary,et al.  Natural history and histological classification of atherosclerotic lesions: an update. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[40]  H. Wellens,et al.  Biphasic pattern of cell turnover characterizes the progression from fatty streaks to ruptured human atherosclerotic plaques. , 1999, Cardiovascular research.

[41]  W. Jacob,et al.  Apoptosis and related proteins in different stages of human atherosclerotic plaques. , 1998, Circulation.

[42]  P. Fiorina,et al.  Perioperative myocardial cell damage assessed by immunoradiometric assay of beta-myosin heavy chain serum levels in patients undergoing coronary bypass surgery. , 1997, International journal of cardiology.

[43]  Y. Yazaki,et al.  Novel biochemical diagnostic method for aortic dissection. Results of a prospective study using an immunoassay of smooth muscle myosin heavy chain. , 1996, Circulation.

[44]  T. Mikawa,et al.  Pericardial mesoderm generates a population of coronary smooth muscle cells migrating into the heart along with ingrowth of the epicardial organ. , 1996, Developmental biology.

[45]  Y. Hiroi,et al.  Diagnosis of aortic dissection by immunoassay for circulating smooth muscle myosin , 1995, The Lancet.

[46]  A. Becker,et al.  Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. , 1994, Circulation.

[47]  Y. Yazaki,et al.  Human smooth muscle myosin heavy chain isoforms as molecular markers for vascular development and atherosclerosis. , 1993, Circulation research.

[48]  M. Davies,et al.  Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophage, and smooth muscle cell content. , 1993, British heart journal.

[49]  J. Léger,et al.  Myosin: a highly sensitive indicator of myocardial necrosis after cardiac operations. , 1989, The Journal of thoracic and cardiovascular surgery.

[50]  M. Kuro-o,et al.  Identification of two types of smooth muscle myosin heavy chain isoforms by cDNA cloning and immunoblot analysis. , 1989, The Journal of biological chemistry.